Dr. Scott Friedman, MD, is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai.
The Icahn School of Medicine at Mount Sinai is hosting its sixth annual SINAInnovations conference. This year’s theme “Cancer” will include keynote addresses, short talks, panel discussions and breakout sessions featuring international thought leaders across the range of relevant domains. Sessions and lectures will include: Cancer Immunology; Immunotherapy & Immune Monitoring; Viruses and Cancer; Cancer Genetics and Genomics; Personalized omics, Cancer Risk and Management; Novel Therapeutics in Cancer and Post Genomic Age; and Cancer Survivorship and Disparities. The conference will define the astonishing advances in cancer and outline solutions to overcome obstacles to progress.
The Icahn School of Medicine at Mount Sinai is hosting its sixth annual SINAInnovations conference. This year’s theme “Cancer” will include keynote addresses, short talks, panel discussions and breakout sessions featuring international thought leaders across the range of relevant domains. Sessions and lectures will include: Cancer Immunology; Immunotherapy & Immune Monitoring; Viruses and Cancer; Cancer Genetics and Genomics; Personalized omics, Cancer Risk and Management; Novel Therapeutics in Cancer and Post Genomic Age; and Cancer Survivorship and Disparities. The conference will define the astonishing advances in cancer and outline solutions to overcome obstacles to progress.
Dr. Scott Friedman SinaInnovations neurology department | |
4 Likes | 4 Dislikes |
294 views views | 36K followers |
Education | Upload TimePublished on 9 Aug 2017 |
Không có nhận xét nào:
Đăng nhận xét